Pornography Abstinence and Nocturnal Erections in Adult Men
A Real-World Observational Study Evaluating the Effects of 30 Days of Pornography Abstinence on Nocturnal Penile Tumescence, Sexual Function, and Well-Being in Adult Men
The effects of pornography use on male sexual health remain uncertain, with mixed findings across existing literature and substantial variability at the individual level. This observational study is designed to help participants evaluate how a 30-day period of pornography abstinence affects their own sexual health and well-being, with a specific focus on nocturnal penile tumescence as a physiological biomarker.
Participants will complete a short baseline observation period during which they maintain their usual pornography consumption patterns, followed by a 30-day abstinence period. Objective nocturnal erection data will be collected using a connected wearable device, alongside validated self-report questionnaires assessing erectile function, sexual desire, mood, energy, and emotional well-being. Participants serve as their own control, allowing for within-person comparisons of outcomes before and during the abstinence period.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
This single-arm, real-world observational study evaluates the association between pornography abstinence and changes in nocturnal penile tumescence, sexual function, and psychosocial outcomes in adult men.
During an initial baseline phase, participants continue their typical pornography use while collecting objective nocturnal erection data and completing baseline questionnaires. Participants then enter a 30-day abstinence period, during which they attempt to refrain from pornography use. Abstinence adherence is self-reported, with lapses logged as observational data rather than protocol violations.
Nocturnal penile tumescence is assessed nightly using the Adam Sensor, a non-invasive wearable device that measures changes in penile circumference during sleep. Additional outcomes are assessed using validated questionnaires administered at baseline and at weekly intervals. The study is exploratory and signal-detecting in nature and is not designed to establish causality.
Study Design
Study Type: Observational
Study Design: Single-arm, within-participant comparison
Time Perspective: Prospective
Masking: None (Open Label)
Primary Purpose: Health outcomes assessment / signal detection
Additional information can be found at the study recruitment landing page here: https://app.efforia.com/30-day-tv-abstinence-challenge/
Tipo di studio
Iscrizione (Stimato)
Contatti e Sedi
Contatto studio
- Nome: Matthew Amsden
- Numero di telefono: (646) 679-2479
- Email: help@efforia.com
Luoghi di studio
-
-
New York
-
New York, New York, Stati Uniti, 10003
- Reclutamento
- Efforia
-
Contatto:
- Matthew Amsden
- Numero di telefono: (646) 679-2479
- Email: help@efforia.com
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Adult males of legal age of consent
- Willingness to attempt pornography abstinence
- Ability to use a wearable device during sleep
- Ability to complete electronic surveys
- Willingness to purchase the study device
Exclusion Criteria:
- Have a history of significant sexual dysfunction requiring active medical treatment
- Have current or uncontrolled mental health disorders
- Have a history of addictive behaviors that may be exacerbated by abstinence
- Are undergoing hormonal therapy or treatment affecting sexual function
- Are experiencing unstable interpersonal or relationship stressors
- Have significant concerns about privacy related to sexual health data
- Have cultural or religious considerations that could cause distress
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
Intervento / Trattamento |
|---|---|
|
Single Arm longitudinal where participants act as their own control
|
Participants will attempt to abstain from all pornography use for 30 consecutive days.
Any deviations from abstinence are self-reported and logged for contextual analysis.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Nocturnal Penile Tumescence
Lasso di tempo: Baseline Day to Day 38
|
Measure: Adam Sensor - Nocturnal Erection Tracking Description: Objective measurement of nocturnal penile tumescence, Frequency/Time nocturnal erections per night |
Baseline Day to Day 38
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Change in Erectile Function
Lasso di tempo: Baseline to Day 38 after intervention
|
Measure: International Index of Erectile Function (IIEF-15) Scale Range: 5-75 (higher scores indicate better erectile and sexual function) Description: Assesses erectile function, orgasmic function, sexual desire, intercourse satisfaction, and overall satisfaction. |
Baseline to Day 38 after intervention
|
|
Change in Sexual Desire
Lasso di tempo: Baseline to Day 38 after intervention
|
Measure: Sexual Desire Inventory-2 (SDI-2) Scale Range: 0-112 (higher scores indicate greater sexual desire) Description: Measures both dyadic and solitary sexual desire. |
Baseline to Day 38 after intervention
|
|
Change in Pornography Consumption Patterns
Lasso di tempo: Baseline to Day 38 after intervention
|
Measure: Weekly Pornography Consumption Survey (custom self-report) Scale: Frequency and duration categories (ordinal) Description: Tracks self-reported pornography use and abstinence adherence. |
Baseline to Day 38 after intervention
|
|
Change in Mood, Energy, and Emotional Well-Being
Lasso di tempo: Baseline to Day 38 after intervention
|
Measure: Weekly Self-Assessment Check-In (custom) Scale: 1-10 Likert-type scales (higher scores indicate more favorable states) Description: Assesses perceived mood, mental clarity, energy level, and emotional resilience. |
Baseline to Day 38 after intervention
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 38321
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .